Autoimmune Diseases

Generation Bio jettisons 90% of employees, including R&D org

Generation Bio is shedding 90% of its workforce after the biotech acknowledged it’s unlikely to find cash to take its lipid nanoparticle tech further.

James Waldron Aug 13, 2025 5:00am

Novartis scores 3rd phase 3 win for ianalumab this week

Aug 12, 2025 5:09am

Novartis scores double phase 3 win in Sjögren's syndrome

Aug 11, 2025 4:33am

christmas cash gift money present holiday

BMS hands 5 autoimmune drugs to Bain-backed spinout

Jul 29, 2025 5:08am

A one dollar bill sitting next to a declining stock graph

Fierce Pharma

Vor Bio's surprise $4B revival deal splits investor reactions

Jun 26, 2025 10:55am

bee flying away bee nectar flower pollen plant lilac

Nektar stock doubles as phase 2b eczema trial hits endpoints

Jun 24, 2025 9:20am